Published in Psychiatr Genet on December 01, 2005
The genetics of addiction-a translational perspective. Transl Psychiatry (2012) 1.30
Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol (2010) 1.14
A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology (2008) 1.07
The genetics of the opioid system and specific drug addictions. Hum Genet (2012) 1.04
Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression. Proc Natl Acad Sci U S A (2008) 1.03
ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. JAMA Psychiatry (2013) 1.02
Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly. J Neural Transm (Vienna) (2009) 0.85
Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity. Addict Biol (2010) 0.84
Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene. Biol Psychol (2011) 0.78
A Functional 3'UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits. Neuropsychopharmacology (2016) 0.75
Association between VNTR Polymorphism in Promoter Region of Prodynorphin (PDYN) Gene and Methamphetamine Dependence. Open Access Maced J Med Sci (2015) 0.75
An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction (2014) 8.38
What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry (2006) 8.22
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med (2006) 4.00
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53
Internet gaming disorder and the DSM-5. Addiction (2013) 3.46
Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use. Am J Psychiatry (2004) 3.28
Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA (2013) 3.25
Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry (2002) 3.22
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2006) 3.06
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry (2013) 2.89
The genetic determinants of smoking. Chest (2003) 2.88
Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology (2007) 2.73
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry (2007) 2.60
Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56
The status of disulfiram: a half of a century later. J Clin Psychopharmacol (2006) 2.48
Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry (2007) 2.48
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry (2010) 2.34
Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend (2007) 2.11
Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS One (2008) 2.07
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol (2006) 2.00
Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain (2013) 1.95
Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders. Neuropsychopharmacology (2006) 1.93
Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry (2007) 1.85
Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr (2010) 1.79
A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend (2004) 1.75
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Am J Psychiatry (2005) 1.69
Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses. Addiction (2011) 1.68
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) (2008) 1.67
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63
Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res (2004) 1.62
Personality characteristics of women before and after recovery from an eating disorder. Psychol Med (2004) 1.57
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol (2006) 1.57
Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend (2002) 1.56
Alcohol consumption among older adults in primary care. J Gen Intern Med (2007) 1.55
Temporal patterns of recovery across eating disorder subtypes. Aust N Z J Psychiatry (2008) 1.52
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50
A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes. J Consult Clin Psychol (2010) 1.50
Buprenorphine treatment: factors and first-hand experiences for providers to consider. J Addict Dis (2007) 1.46
Effects of varenicline on smoking cue–triggered neural and craving responses. Arch Gen Psychiatry (2011) 1.45
Design and sample characteristics of the PRISM-E multisite randomized trial to improve behavioral health care for the elderly. J Aging Health (2004) 1.45
A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry (2011) 1.45
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav (2002) 1.44
Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients. J Addict Dis (2004) 1.43
Features associated with excessive exercise in women with eating disorders. Int J Eat Disord (2006) 1.40
Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry (2008) 1.40
Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene. Mamm Genome (2004) 1.39
Application of a latent class analysis to empirically define eating disorder phenotypes. Arch Gen Psychiatry (2004) 1.39
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) study. Am J Addict (2007) 1.37
Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res (2004) 1.37
Family problems among recently returned military veterans referred for a mental health evaluation. J Clin Psychiatry (2009) 1.35
Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat (2004) 1.35
Older patients' aversion to antidepressants. A qualitative study. J Gen Intern Med (2005) 1.35
Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry (2013) 1.33
DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology (2008) 1.31
Relationships between features associated with vomiting in purging-type eating disorders. Int J Eat Disord (2005) 1.31
The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend (2009) 1.30
Importance of subsyndromal symptoms of depression in elderly patients. Am J Geriatr Psychiatry (2005) 1.28
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27
Alcohol use disorder comorbidity in eating disorders: a multicenter study. J Clin Psychiatry (2004) 1.26
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs (2011) 1.25
Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. PLoS Genet (2011) 1.23
Linkage analysis of anorexia nervosa incorporating behavioral covariates. Hum Mol Genet (2002) 1.20
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18
Smoking in eating disorders. Eat Behav (2006) 1.18
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend (2006) 1.17
Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol (2011) 1.16
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res (2008) 1.15
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) (2007) 1.15
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials (2008) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry (2004) 1.13
Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics (2005) 1.13
Patterns of menstrual disturbance in eating disorders. Int J Eat Disord (2007) 1.13
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13
PRISM-E: comparison of integrated care and enhanced specialty referral models in depression outcomes. Psychiatr Serv (2006) 1.12
The association between chronic pain and prescription drug abuse in Veterans. Pain Med (2009) 1.12
Genetic analysis of bulimia nervosa: methods and sample description. Int J Eat Disord (2004) 1.11
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav (2007) 1.11
Alcohol potentiates hepatitis C virus replicon expression. Hepatology (2003) 1.11
Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet (2010) 1.11
Alcohol and drug use disorders among adults in emergency department settings in the United States. Ann Emerg Med (2012) 1.11
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics (2009) 1.10
Substance use disorders in women with anorexia nervosa. Int J Eat Disord (2010) 1.10